Most Relevant Terms per Topic

Abstracts with Biological Entities (English) - 75 Topics / Sub-Topic Model 56

Topic 1 Topic 2 Topic 3 Topic 4 Topic 5 Topic 6 Topic 7 Topic 8 Topic 9 Topic 10 Topic 11 Topic 12 Topic 13 Topic 14 Topic 15
1 virus infection ZIKV detection CCHFV EBOV EVD LASV nss DENV aegypti viruses de SFTSV RGN
2 disease cell zika WNV vaccine ebola sierra lassa RVFV dengue aedes innate el SFTS natal
3 fever cells zika virus assay CCHF ebola virus leone arenavirus RVF serotypes mosquito NW dengue ab10 hantaviruses
4 infections virus microcephaly nile challenge ebolavirus ebola virus disease arenaviruses valley dengue virus NIRVS RNA DHF/DSS oshima genotypes
5 clinical vitro pregnant encephalitis antibodies GP sierra leone lassa fever SFSV DIII mosquitoes contribute en gn DENV-2
6 africa activity fetal equine mice marburg international lassa virus rift CHIKV A. single-stranded las thrombocytopenia urban
7 outbreaks viral complications bats neutralizing marburg virus ebola MOPV phlebovirus serotype albopictus belong DV sftsv infection sylvatic
8 review JEV congenital sera neutralizing antibodies E-S-FLU outbreak LF bunyaviridae ERI3 ae ocular dengue fever UPR disorder
9 health drug neurological west nile virus protection filovirus 2014 tfr1 MP-12 mabs scapularis filovirus con 08-as côte
10 infection entry anti-zikv positive JUNV MARV liberia LCMV family bunyaviridae TF CHIKV filovirus disease fiebre thrombocytopenia syndrome d’ivoire
11 chikungunya antiviral adults ELISA expressing BCX4430 island mammarenaviruses IFN million crosse OW paper sfts virus côte d’ivoire
12 cases identified zika virus infection DENV-4 attenuated anti-ebola concern machupo degradation genus flavivirus DENV4 primate coronavirus NSDV codon
13 humans study strains % protected e-s-flu virus patients ATP1A1 PKR conformation I. immune infants host cell srips
14 viral therapeutic brazil test crimean-congo nonhuman rapid junin gc immunity vector chapter day 5–10 shell
15 models treatment pregnancy samples titers zaire populations ITCH rift valley fever virus mab adaptation VHF blood therapeutic agent c protein
16 recent in vitro AR-12 flaviviruses prevent clomiphene presenting host factors sandfly DHF aedes aegypti negative-strand ratio TBEV r(2
17 animal mechanism women VEEV MAYV filoviridae case n-glycosylation genus phlebovirus DI/DII arboviruses innate immune response indic recovered YFV
18 countries inhibited emergency serological immune responses mabs contagious mammarenavirus virulence PRINT V920 families 5th 272 rainforest
19 associated with inhibitors defects specificity horse containment colombia endemic regions genus intraviral a. albopictus uorfs guidelines japan neurotropic
20 hemorrhagic replication neurological complications western envelope GP1 planning life synthesis antibody-dependent enhancement aedes albopictus paramyxoviruses remote hokkaido CAI
21 mortality found fetal microcephaly virus mouse amps guinea world sandfly fever srece vectors hantavirus risk 247 rescued
22 current effect gossypol revealed induce ER transmission steps lacking donors la positive-sense epidemiological thrombocytopenia syndrome virus park
23 chikungunya virus compounds guillain-barré selected immunization ebolaviruses period interactions IRF3 enhancement culex genome fever tick-borne june
24 febrile targets infected sensitivity vaccinated VSV potentially arenaviral protein dengue infection a. aegypti host dengue hemorrhagic fever china cuba
25 development drugs abnormalities immunosorbent humoral surface organization partially phleboviruses m366.6 indian filoviruses primary host values
26 acute cellular syndrome benzavir-2 TCRV antibody care choriomeningitis M847 expressed mosquito vector flaviviruses nipah korea RT
27 severe domain barré primers lethal biosafety R(0 process nss protein antibody-dependent arthropods family su proteomic CFR
28 endemic production testicular sensitive responses monoclonal persons OST MRC-5 antigens 2005 prototype CD209 spectrometry DR
29 illness highly vertical neutralization efficacy anti-ebov largest guanarito mrna examined la crosse virus profiling laboratory diagnosis predict inflict
30 including proteins sperm japanese recombinant bearing world health organization old world virulence factor dengue viruses 31N systemic riesgo isolates PID
31 human binding asian NS1 protective pseudotypes epidemic arenavirus infection DIVA estimated v920 vaccine leading epidemias infectious disease neighboring
32 west mechanisms fetuses capture MVA-CHIK sudan french polynesia arenaviridae ifn-β spectrum autochthonous ribosome profiling por reacted 2006
33 emerging active infection flavivirus passive isomers health ML29 rmp12-ptnss dengue vaccine i. scapularis ribosome definitive viral multiplication EGFP
34 morbidity inhibitory 2015 plaque disseminated survivors oceania involved rift valley fever tetravalent ocean define día cellular responses higher
35 south library ery-est BTV D746 glycoprotein guatemala essential truncated joint U.S. reoviruses hasta hemorrhage =
36 limited target 409 CONCLUSION eastern europe filoviruses countries/territories multiplication rmp12-sfsnss ppis E2-L210Q polyprotein children alanine found
37 threat inhibitor fetus PRNT enhance full-length lung cycle tripartite germline-like larvae ocular manifestations south america HB28 variation
38 molecular fusion male venezuelan equine encephalitis virus horses 1976 suriname host phosphorylation oligomerization spp adaptive immunity secondary ATF6 strain
39 increased mice congenital zika syndrome west immunogenicity rvsv-based migration west africa mrc-5 cells challenging quinquefasciatus ssrna epidemics SD4 discovered
40 potential potential guillain-barre antibodies E298 ebolavirus species 2013–2016 anti-mammarenavirus self-limiting evolved ocean islands pathogenesis occidental scanning synthesizes
41 public health protein malformations results vaccines filoviral declared MAGT1 chadox1 contacts aedes spp members dv infection non-linear 6.25
42 research effective birth TABV immune facilities wave vrnp domestic nanoparticles florida responses se biological processes shrews
43 worldwide prophylactic zika ns2b-ns3pro SUPPLEMENTARY study VP40 2016 TUSC3 host palmitoylation county discuss resumen cross-linker uncovered
44 licensed aahig mothers authorized high entry time sabia factor NS2B female BRB exposures gangwon/korea/2012 circulate
45 animal models nervous birth defects online ankara virus worker STT3B-OST fever billion land flow journey phage-displayed noteworthy
46 vaccine enhanced Z2 version tick-borne disease species rico STT3B cells allosteric publications dendritic cells epidemiological control cell membrane fusion molecularly
47 trials countermeasures pregnant women DKNV testes pseudovirus martin prototypic family antigenically transmission APC menace 1995 fine-tuning
48 progress lines guillain-barré syndrome material vaccinia reston KGH virus infectivity punta toro virus golgi two-year threats collapse stem sophisticated
49 past CHK2 semen bat hamsters biosafety level recrudescence mastomys natalensis eif2α confers manatee cytokines identifiable alteration dutch
50 clinical trials combination epidemic species competent anti-filovirus puerto transferrin toro ns triseriatus uorf count/basic goat predictor